Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	148.86B
Revenue (ttm)	15.54B
Net Income (ttm)	1.38B
Shares Out	208.47M
EPS (ttm)	7.33
PE Ratio	97.40
Forward PE	68.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	236,819
Average Volume	746,197
Open	717.00
Previous Close	719.70
Day's Range	710.50 - 726.00
52-Week Range	636.10 - 808.80
Beta	n/a
RSI	50.76
Earnings Date	May 14, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Commercial Physical and Biological Research
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2023, Sai Life Sciences's revenue was 14.65 billion, an increase of 20.38% compared to the previous year's 12.17 billion. Earnings were 828.09 million, an increase of 729.00%.